Sun Pharma Shares Hit 52-Week High Post Acquiring Israels Libra Merger Ltd | Stock Market News
Sun Pharma hits a new high after acquiring Israel's Libra Merger, consolidating its presence in the region. This follows a recent US investment in Lyndra Therapeutics. We break down the deals and their potential impact on Sun Pharma's future.
Written By: Zee Business Video Team